denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Sponsor: Regeneron Pharmaceuticals, Inc., Sanofi, and Takeda Pharmaceuticals U.S.A., Inc.
Program: Friday Satellite Symposia
Hematology Disease Topics & Pathways:
Diversity, Equity, and Inclusion (DEI) , Therapies
Hematology Disease Topics & Pathways:
Diversity, Equity, and Inclusion (DEI) , Therapies
Friday, December 8, 2023: 7:00 AM-10:00 AM
Room 6A
(San Diego Convention Center)
Chair:
Irene M. Ghobrial, MD, Dana-Farber Cancer Institute
Disclosures:
Ghobrial: Sanofi: Consultancy, Honoraria; Huron Consulting: Consultancy; Regeneron: Consultancy, Honoraria; Adaptive: Honoraria; Aptitude Health: Consultancy; Window Therapeutics: Consultancy; Novartis: Consultancy, Honoraria, Research Funding; Janssen: Consultancy, Honoraria; Oncopeptides: Consultancy; Pfizer: Consultancy, Honoraria; Menarini Silicon Biosystems: Consultancy, Honoraria; The Binding Site: Consultancy; GlaxoSmithKline: Consultancy, Honoraria; AbbVie: Consultancy, Honoraria; 10x Genomics: Honoraria; Disc Medicine: Other: Spouse is Chief Medical Officer and holds equity in the company; Vor Biopharma: Ended employment in the past 24 months, Honoraria, Speakers Bureau; Takeda: Consultancy, Honoraria; Janssen: Consultancy, Honoraria; Amgen: Consultancy; Bristol-Myers Squibb: Consultancy, Honoraria.
Speakers:
Craig Emmitt Cole, MD, Michigan State University
and
Omar Nadeem, MD, Dana-Farber Cancer Institute
Disclosures:
Cole: Oncopeptides: Consultancy; Sanofi: Consultancy; Pfizer: Consultancy; AstraZeneca: Consultancy; Abbvie: Consultancy; GSK: Research Funding. Nadeem: Takeda: Membership on an entity's Board of Directors or advisory committees, Research Funding; GSK: Membership on an entity's Board of Directors or advisory committees; BMS: Membership on an entity's Board of Directors or advisory committees; GPCR Therapeutics: Membership on an entity's Board of Directors or advisory committees; Sanofi: Membership on an entity's Board of Directors or advisory committees; Janssen: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding.
Access Program Details
This agenda format designed to bring together faculty together to have open conversations about the pressing issue of healthcare inequities seen in practice. This peer-to-peer exchange will foster and open and honest discussion on inequities and potential interventions that can be implemented to improve care for all patients with multiple myeloma.
See more of: Friday Satellite Symposia